Current Challenges and Opportunities in Treating Glioblastoma

Area of Science:

• Neuro-oncology
• Genomics
• Drug Discovery

Background:

• Glioblastoma multiforme (GBM) is an aggressive brain tumor with high mortality.
• Tumor heterogeneity contributes to treatment resistance and recurrence.
• Identifying novel drug targets and improving drug delivery are critical for GBM treatment.

Purpose of the Study:

• To identify and validate novel drug targets for glioblastoma.
• To review recent advancements in GBM drug discovery and delivery strategies.
• To assess the blood-brain barrier (BBB) permeability of potential GBM therapeutics.

Main Methods:

• Bioinformatics analysis of The Cancer Genome Atlas (TCGA) data to identify overexpressed genes in GBM.
• Computational multi-parameter optimization for assessing blood-brain barrier (BBB) permeability.
• Review of current literature on GBM drug discovery and delivery methods.

Main Results:

• Identified 20 genes overexpressed in a GBM subpopulation, correlating with poor survival.
• Nine genes showed higher expression in GBM compared to low-grade glioma, suggesting a role in disease progression.
• Computational analysis provided insights into BBB permeability for small molecules in clinical trials.

Conclusions:

• The identified genes represent potential biomarkers and therapeutic targets for GBM.
• Novel drug delivery systems like nanoparticles and prodrugs are crucial for overcoming BBB challenges.
• Targeting these genes and optimizing delivery could lead to improved GBM treatment outcomes.